BRLI Financial Facts
WEIGHTED AVERAGE NUMBER OF SHARES - DILUTED: (in shares): 27.88MDepreciation and Amortization: 1.61M
See Full Income Statement
Long - Term Debt -- Net of Current Portion: 2.87M
Current Maturities of Long-Term Debt: 541K
See Full Balance Sheet
Bio-Reference Laboratories Inc. (BRLI) Earnings
|
Expand Research on BRLI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/14  |
 |
Q114 | N/A | $0.15 | N/A | N/A | $175.52M | N/A | N/A | N/A | |
| 3/3/11 |
|
Q111 | $0.28 | $0.17 | +$0.11 | $121.66M | $119.12M | N/A |  | | Details |
| 3/1/12 |
|
Q112 | $0.26 | $0.21 | +$0.05 | $149.92M | $143.13M | N/A | | | Details |
| 5/26/11 | Q211 | $0.26 | $0.25 | +$0.01 | $137.7M | $131.2M | N/A | | | Details | |
| 2/28/13 |
Q113 | $0.34 | $0.28 | +$0.06 | $161.26M | $165.44M | N/A | | | Details | |
| 12/16/10 |
|
Q410 | $0.31 | $0.30 | +$0.01 | N/A | N/A | N/A | | | Details |
| 6/7/12 |
|
Q212 | $0.33 | $0.32 | +$0.01 | $163.4M | $161.48M | N/A | | | Details |
| 6/5/14 |
|
Q214 | $0.37 | $0.32 | +$0.05 | $201.4K | $195.64K | N/A | | | Details |
